Try our beta test site
387 studies found for:    Muscular Dystrophy
Show Display Options
Rank Status Study
21 Recruiting An Open-label Extension Study To Evaluate Safety Of PF-06252616 In Boys With Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Intervention: Biological: PF-06252616
22 Withdrawn Test-Retest Reliability of Pulmonary Function Tests in Patients With Duchenne's Muscular Dystrophy
Conditions: Duchenne's Muscular Dystrophy;   Scoliosis
Intervention:
23 Recruiting DuchenneConnect Registry
Conditions: Duchenne Muscular Dystrophy;   Becker Muscular Dystrophy
Intervention:
24 Recruiting A Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)
Condition: Duchenne Muscular Dystrophy
Interventions: Drug: Vamorolone 0.25 mg/kg/day;   Drug: Vamorolone 0.75 mg/kg/day;   Drug: Vamorolone 2.0 mg/kg/day;   Drug: Vamorolone 6.0 mg/kg/day
25 Active, not recruiting Safety, Tolerability, Pharmacokinetics, and Biological Activity of ATYR1940 in Adult Patients With Muscular Dystrophy
Condition: Facioscapulohumeral Muscular Dystrophy (FSHD)
Intervention: Biological: ATYR1940
26 Recruiting An Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)
Condition: Duchenne Muscular Dystrophy
Interventions: Drug: Vamorolone 0.25 mg/day/day;   Drug: Vamorolone 0.75 mg/day/day;   Drug: Vamorolone 2.0 mg/day/day;   Drug: Vamorolone 6.0 mg/day/day
27 Recruiting A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of PF-06252616 in Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Interventions: Biological: PF-06252616;   Drug: Placebo
28 Active, not recruiting Dose-Titration and Open-label Extension Study of SRP-4045 in Advanced Stage Duchenne Muscular Dystrophy (DMD) Patients
Condition: Duchenne Muscular Dystrophy
Interventions: Drug: SRP-4045;   Drug: Placebo
29 Not yet recruiting Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of BMS-986089 in Ambulatory Boys With Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Interventions: Biological: BMS-986089;   Biological: Placebo for BMS-986089
30 Unknown  Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Intervention: Biological: human umbilical cord mesenchymal stem cells
31 Completed Tadalafil and Sildenafil for Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Interventions: Drug: Tadalafil;   Drug: Sildenafil
32 Completed L-citrulline and Metformin in Duchenne's Muscular Dystrophy
Condition: Duchenne's Muscular Dystrophy (DMD)
Interventions: Drug: 750 mg metformin and 7.5 g L-citrulline daily p.o.;   Drug: Placebo
33 Completed Stem Cell Therapy in Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Intervention: Biological: Stem Cell
34 Completed Gentamicin Treatment of Muscular Dystrophy
Conditions: Becker Muscular Dystrophy;   Duchenne Muscular Dystrophy
Intervention: Drug: Gentamicin
35 Completed Stem Cell Therapy in Limb Girdle Muscular Dystrophy
Condition: Limb Girdle Muscular Dystrophy
Intervention: Biological: Autologous bone marrow mononuclear cell transplantation
36 Withdrawn Drisapersen Duchenne Muscular Dystrophy (DMD) Treatment Protocol
Condition: Muscular Dystrophies
Intervention: Drug: Drisapersen
37 Completed Evaluation of Limb-Girdle Muscular Dystrophy
Conditions: Becker Muscular Dystrophy;   Limb-Girdle Muscular Dystrophy, Type 2A (Calpain-3 Deficiency);   Limb-Girdle Muscular Dystrophy, Type 2B (Miyoshi Myopathy, Dysferlin Deficiency);   Limb-Girdle Muscular Dystrophy, Type 2I (FKRP-deficiency)
Intervention:
38 Recruiting Study of DS-5141b in Patients With Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Intervention: Drug: DS-5141b
39 Completed Cell Therapy in Limb Girdle Muscular Dystrophy
Condition: Limb Girdle Muscular Dystrophy
Intervention: Biological: Stem Cell
40 Active, not recruiting Longitudinal Study of the Natural History of Duchenne Muscular Dystrophy (DMD)
Condition: Duchenne Muscular Dystrophy
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.